GT BIOPHARMA, INC. (GTBP) Capital expenditures 2011–2019
GT BIOPHARMA, INC. (GTBP) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2019 · since FY2011: $0 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | $0 | -100.0% |
| FY2018 | $36,000 | +800.0% |
| FY2017 | $4,000 | — |
| FY2016 | $0 | -100.0% |
| FY2015 | $1,000 | -83.3% |
| FY2014 | $6,000 | — |
| FY2013 | $0 | -100.0% |
| FY2012 | $2,000 | — |
| FY2011 | $0 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice